摘要
目的:观察压缩雾化吸入布地奈德治疗小儿支气管哮喘的临床效果。方法:选取2012年1月~2016年1月前来我院就诊的急性支气管哮喘发作期的患儿78例作为观察对象,随机分为雾化组与对照组,对照组给予常规药物或吸氧治疗,雾化组在对照组基础上加用压缩雾化吸入布地奈德混悬液进行治疗。治疗一周后,比较两组治疗有效率及主要症状消失时间。结果:雾化组治疗总有效率89.74%,对照组总有效率69.23%,组间比较有显著差异(P<0.05);雾化组主要症状消失时间均少于对照组,比较有显著差异(P<0.05)。结论:配合使用压缩雾化吸入布地奈德混悬液治疗小儿支气管哮喘,疗效确切见效快,建议临床可广泛应用。
Objective： to observe the compression atomizing inhalation of budesonide in the treatment of infantile bronchial asthma effect.Methods： between January 2014 and January 2014 to come to our hospital with acute bronchial asthma episodes of 78 cases of children as research object,were randomly divided into atomization group and the control group,control group to give children medications or oxygen treatment,the atomization group in the control group on the basis of the total compression atomizing inhalation budesonide suspension liquid treatment. A week after treatment,compared two groups of children with treatment efficient and main symptoms disappear time. Results： the atomization group treatment the total effective rate was 89.74%,there are differences between the control group total effective rate 69.23%,the comparison between groups（P0.05）; Children of the main symptoms disappear time atomization group were less than the control group,children more difference（P0.05）. Conclusion： using compressed inhaled budesonide suspension liquid treatment of infantile bronchial asthma,curative effect,quick results suggested that clinical can be widely used.
出处
《北方药学》
2017年第2期12-13,共2页
Journal of North Pharmacy
关键词
压缩雾化吸入
儿童
支气管哮喘
布地奈德
Compressing atomized inhalation
Children
Bronchial asthma
Budesonide
